Nan Shan Life Insurance’s Edwards Lifesciences EW Stock Holding History

Nan Shan Life Insurance’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50M	Hold	552,221	–	–	1.57%	22
2026 Q1	$44.2M	Hold	552,221	–	–	1.6%	22
2025 Q4	$47.1M	Hold	552,221	–	–	1.45%	19
2025 Q3	$42.9M	Hold	552,221	–	–	0.91%	32
2025 Q2	$43.2M	Hold	552,221	–	–	0.96%	31
2025 Q1	$40M	Hold	552,221	–	–	0.94%	33
2024 Q4	$40.9M	Hold	552,221	–	–	0.98%	37
2024 Q3	$36.4M	Buy	552,221 +25,919	+5%	+$1.88M	0.86%	38
2024 Q2	$48.6M	Buy	526,302 +344,502	+189%	+$30.5M	1.15%	23
2024 Q1	$17.4M	Buy	+181,800	New	+$15.3M	0.41%	68
2018 Q3	–	Sell	-739,974	Closed	-$35.9M	–	111
2018 Q2	$35.9M	Sell	739,974 -223,335	-23%	-$10.4M	0.83%	34
2018 Q1	$44.8M	Sell	963,309 -1,255,074	-57%	-$54.5M	0.91%	31
2017 Q4	$83.3M	Buy	2,218,383 +60,000	+3%	+$2.2M	2.16%	18
2017 Q3	$78.6M	Buy	2,158,383 +1,829,883	+557%	+$69.8M	1.63%	23
2017 Q2	$12.9M	Buy	+328,500	New	+$12M	0.33%	43

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Nan Shan Life Insurance's EW Position: Q2 2026 in Review

Nan Shan Life Insurance held its Edwards Lifesciences (EW) position steady in Q2 2026 at 552,221 shares worth $50M. The position accounts for 1.57% of the portfolio, ranked #22.

Nan Shan Life Insurance first reported a position in EW in Q2 2017 and has held it in 15 quarters since. The position peaked at $83.3M in Q4 2017. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Nan Shan Life Insurance held 552,221 shares of Edwards Lifesciences worth $50M as of Q2 2026.
Nan Shan Life Insurance left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 1.57% of Nan Shan Life Insurance's portfolio in Q2 2026, its #22 holding.
Nan Shan Life Insurance first reported a position in Edwards Lifesciences in Q2 2017 and has held it in 15 quarters since.
Nan Shan Life Insurance's Edwards Lifesciences position peaked at $83.3M in Q4 2017.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Nan Shan Life Insurance's 13F filing for Q2 2026, filed 14 Aug 2026.